ZA965235B - Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders - Google Patents

Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders

Info

Publication number
ZA965235B
ZA965235B ZA965235A ZA965235A ZA965235B ZA 965235 B ZA965235 B ZA 965235B ZA 965235 A ZA965235 A ZA 965235A ZA 965235 A ZA965235 A ZA 965235A ZA 965235 B ZA965235 B ZA 965235B
Authority
ZA
South Africa
Prior art keywords
prophylaxis
pharmaceutical
treatment
gastrointestinal disorders
pct
Prior art date
Application number
ZA965235A
Other languages
English (en)
Inventor
Christoph De Haen
Luigia Gozzini
Original Assignee
Bracco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Spa filed Critical Bracco Spa
Publication of ZA965235B publication Critical patent/ZA965235B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
ZA965235A 1995-06-23 1996-06-20 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders ZA965235B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001359A IT1276783B1 (it) 1995-06-23 1995-06-23 Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali

Publications (1)

Publication Number Publication Date
ZA965235B true ZA965235B (en) 1997-01-09

Family

ID=11371866

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA965235A ZA965235B (en) 1995-06-23 1996-06-20 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders

Country Status (18)

Country Link
US (1) US6007808A (es)
EP (1) EP0833644B1 (es)
JP (1) JPH11507934A (es)
CN (1) CN1082373C (es)
AT (1) ATE234623T1 (es)
AU (1) AU707399B2 (es)
BR (1) BR9609413A (es)
CA (1) CA2219739A1 (es)
DE (2) DE833644T1 (es)
DK (1) DK0833644T3 (es)
ES (1) ES2194107T3 (es)
HU (1) HUP9901707A3 (es)
IT (1) IT1276783B1 (es)
MX (1) MX9709238A (es)
NO (1) NO976048L (es)
NZ (1) NZ312121A (es)
WO (1) WO1997000688A1 (es)
ZA (1) ZA965235B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20040166101A1 (en) * 1999-09-22 2004-08-26 Bojrab Gregory G. Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
US6641808B1 (en) 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
CA2407724A1 (en) * 2000-05-03 2001-11-08 University Of Maryland, Baltimore Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal
US7112570B2 (en) * 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
JP4559380B2 (ja) * 2002-03-01 2010-10-06 日清ファルマ株式会社 肝疾患治療剤
ATE421990T1 (de) * 2002-07-22 2009-02-15 Meito Sangyo Kk Zusammensetzung zur förderung der vermehrung von lactobacillus casei subsp. casei
DK175877B1 (da) * 2002-11-11 2005-05-09 Pharmalett As Præparater til anvendelse som terapeutisk middel
WO2005000034A2 (en) * 2003-06-23 2005-01-06 Agtech Products, Inc. Lactic bacteria and its use in direct-fed microbials
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
DK1880001T3 (da) * 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
AU2006253007B2 (en) * 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
JPWO2007119502A1 (ja) * 2006-03-23 2009-08-27 協和発酵バイオ株式会社 便通改善剤
AU2007245002B2 (en) * 2006-03-29 2012-05-03 Société des Produits Nestlé S.A. Dietary supplements containing probiotics
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
CN101259140B (zh) * 2007-03-08 2012-08-22 重庆北碚现代应用药物研究所 一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
WO2011009848A2 (en) 2009-07-20 2011-01-27 Bracco Spa Therapeutic use of probiotics
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2013099883A1 (ja) 2011-12-28 2013-07-04 株式会社山田養蜂場本社 IgA産生促進作用を有する新規乳酸菌及びその用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5397803A (en) * 1985-09-12 1995-03-14 Brigham And Women's Hospital Use of glutamine to reduce rate of pathogenic microorganism infection
JPH0367046A (ja) * 1989-08-05 1991-03-22 Mitsubishi Motors Corp エンジンの吸入空気量制御装置
CN1105544A (zh) * 1994-09-09 1995-07-26 扬州大学农学院 一种制取活性乳酸菌口服液的方法
US5531681A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding

Also Published As

Publication number Publication date
ITMI951359A0 (it) 1995-06-23
DE833644T1 (de) 1998-09-03
AU6357596A (en) 1997-01-22
NO976048L (no) 1998-02-23
NZ312121A (en) 1999-03-29
BR9609413A (pt) 1999-05-18
ES2194107T3 (es) 2003-11-16
HUP9901707A2 (hu) 1999-09-28
ITMI951359A1 (it) 1996-12-23
DE69626818T2 (de) 2003-11-20
NO976048D0 (no) 1997-12-22
EP0833644B1 (en) 2003-03-19
AU707399B2 (en) 1999-07-08
ATE234623T1 (de) 2003-04-15
CN1082373C (zh) 2002-04-10
MX9709238A (es) 1998-03-31
US6007808A (en) 1999-12-28
HUP9901707A3 (en) 2001-04-28
CN1188413A (zh) 1998-07-22
JPH11507934A (ja) 1999-07-13
WO1997000688A1 (en) 1997-01-09
EP0833644A1 (en) 1998-04-08
IT1276783B1 (it) 1997-11-03
CA2219739A1 (en) 1997-01-09
DE69626818D1 (de) 2003-04-24
DK0833644T3 (da) 2003-07-21

Similar Documents

Publication Publication Date Title
ZA965235B (en) Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
NO952229D0 (no) Anvendelse av karbamazepin og okskarbazepin ved behandling av neurologiske lesjoner relatert til traumatiske skader
MX9706969A (es) 3-(1,2,3,6-tetrahidropiridin-4-il)-1h-indoles y 3-(piperidin-4-il)-1h-indoles sustituidos en la posicion 5: agonistas del 5-ht1f novedosos.
AU677279B2 (en) Application of carbamazepine and oxcarbazepine in the treatment of Parkinson's disease and Parkinsonian syndromes
IL113566A0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
CA2165824A1 (fr) Utilisation du modafinil pour la fabrication d'un medicament ayant un effet sur les apnees du sommeil et les troubles ventilatoires d'origine centrale
ZA984463B (en) Fused dihydropyrans
HU9602051D0 (en) Delta12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
AU1753699A (en) Application of vasopressin antagonists for treating disturbances or illnesses ofthe inner ear
EP1032556A4 (en) PHARMACEUTICALLY EFFECTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
ZA965997B (en) N-(4-substituted-benzyl)-2-aminolactam derivatives
DK0711283T3 (da) Tetrahydro-1H-benzazepinoner og hexahydroazepinoner som selektive cholecystokinin-B-receptorantagonister
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
AU5819394A (en) N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
NZ320522A (en) Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
PL322847A1 (en) Condensed b-carbolins
UA32580C2 (uk) Засіб для лікування паралітичної непрохідності кишечнику